An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.Metabolomics and Its Application in the Development of Discovering Biomarkers for Osteoporosis ResearchComparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trialBone turnover and bone mineral density in HIV-1 infected Chinese taking highly active antiretroviral therapy -a prospective observational study.Human macrophage foam cells degrade atherosclerotic plaques through cathepsin K mediated processesInterpretation of 41Ca data using compartmental modeling in post-menopausal womenProcollagen type I N-terminal propeptide (PINP) is a marker for fibrogenesis in bile duct ligation-induced fibrosis in rats.Chronic kidney disease and osteoporosis: evaluation and management.Effect of folic acid on bone metabolism: a randomized double blind clinical trial in postmenopausal osteoporotic women.Isolation and characterization of human osteoblasts from needle biopsies without in vitro culture.Acute Myocardial Infarction and Pulmonary Diseases Result in Two Different Degradation Profiles of Elastin as Quantified by Two Novel ELISAsAssessment of health claims in the field of bone: a view of the Group for the Respect of Ethics and Excellence in Science (GREES).Characterization of mesenchymal progenitor cells isolated from human bone marrow by negative selectionChronic kidney disease and the skeleton.Age-specific profiles of tissue-level composition and mechanical properties in murine cortical boneOsteoanabolics.Rapidly assessing changes in bone mineral balance using natural stable calcium isotopesEarly changes in blood-based joint tissue destruction biomarkers are predictive of response to tocilizumab in the LITHE study.Extracellular matrix remodeling: the common denominator in connective tissue diseases. Possibilities for evaluation and current understanding of the matrix as more than a passive architecture, but a key player in tissue failure.Moderate alcohol intake lowers biochemical markers of bone turnover in postmenopausal womenOptimizing dosing frequencies for bisphosphonates in the management of postmenopausal osteoporosis: patient considerations.Quarterly intravenous ibandronate for postmenopausal osteoporosis.The efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in antiretroviral regimens for HIV-1 therapy: Meta-analysis.The osteoporosis revolution marches on.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Post-translational modifications of the extracellular matrix are key events in cancer progression: opportunities for biochemical marker development.Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options.A meta-analysis of reference markers of bone turnover for prediction of fracture.Bone turnover markers for early detection of fracture healing disturbances: A review of the scientific literature.Tartrate-resistant acid phosphate as biomarker of bone turnover over the lifespan and different physiologic stages in sheep.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.Bone turnover markers in sheep and goat: A review of the scientific literature.Modeling and simulation of bone mineral density response from a phase 2 study of ONO-5334, a new cathepsin K inhibitor, to support dose selection in osteoporosis.A semi-mechanistic model of bone mineral density and bone turnover based on a circular model of bone remodeling.Changes of Bone Turnover Markers in Long Bone Nonunions Treated with a Regenerative Approach.¹⁸F-fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: a prospective, randomized, controlled clinical study.Low bone turnover phenotype in Rett syndrome: results of biochemical bone marker analysis.Population pharmacokinetic and pharmacodynamic modeling of different formulations of ONO-5334, cathepsin K inhibitor, in Caucasian and Japanese postmenopausal females.Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes.Short-term variability in biomarkers of bone metabolism in sheep.
P2860
Q27687777-D03FB300-7FC2-4C00-BB7B-D2EB9CAC8846Q28068862-B462418A-0A72-40B9-9CEE-B6784AA625AFQ28730855-6CBAC029-6749-4F83-87DE-F2D213FC0F0AQ31124706-C8B93FB6-DF72-4CDF-95D5-29B8A5FA1109Q33561251-5909B69F-BC13-45DF-ACFE-F1E098B6AF93Q33770418-292A459F-0DF7-44EE-ADE1-903D85862E74Q33813357-722D377B-727E-4B7D-87C0-11654FBE9259Q33833414-82959F50-73AF-47F8-BFEC-276C284AE88DQ34233356-5E88D3D4-4F65-4780-A71F-AF8A6426862AQ34437408-83DC5511-6005-495F-AC1B-DDD20F757842Q34785177-36119D10-8515-4E97-84D1-66F58A070D95Q35644141-1A75283A-5A9A-43BF-A02E-718C28D8BCA5Q35754233-D3E2381C-16B7-4F73-8262-CD613D329A10Q35755179-776C3CD5-6929-4543-A777-2EA8D3C43141Q35823045-CFF7A907-8335-4BB8-A12A-E05D8210F3C3Q35967742-68A07CC6-8482-4713-8D67-849FDBA599F4Q36056590-3CAE15E5-385C-4F6C-BFE2-90C1F0D81C26Q36481786-76A543D5-2597-43B7-B309-69890993423CQ36672445-F4F2540B-0B1D-46A1-B788-0D8A56C651E3Q36684990-83AF43C3-F92C-4038-9C1D-19AFE13E40F7Q37192994-18467E24-8A59-4280-B5EC-A35563FEA50EQ37346101-6F3C17DA-8E9C-417D-8497-A61F33FD76A2Q37354871-A2B3037B-E007-41AB-80C4-30A538B5AA7FQ37426033-AA6980E0-0FD1-4D35-882C-3FEE79E017B0Q37462448-82E82280-D134-48FA-8BFF-6833E336AF01Q37867110-817A0BA5-0991-414A-8119-6ACF21851828Q37951107-8EF520C2-AA9C-43E5-A5D5-28C7E26DF26EQ38192911-C6DE337D-98A2-442D-A532-91A8358450E5Q38494091-BE378054-216C-4CF9-8807-DF5A7620E5D4Q38623456-23EC76EF-3627-4E2F-AA0D-A8D1FA8CCCC5Q38675211-44865C0F-3BFE-444C-9B08-0D16E928D8F7Q39168502-10DA9010-B733-44D3-BB94-6FBBDEE9AA97Q39234438-D364D860-6541-4CAB-AB29-5EC394E017ADQ40783785-700A9AAB-2043-41A4-B842-7B88D78BB873Q40990126-96A10C4A-24CD-47C8-AC5A-287B4134EEDCQ46162569-4790AFE7-D3D3-4E95-879F-05C22FD2EFBEQ46655041-6B3F3820-D09E-4B52-B7E3-25DDAC0D6050Q51152617-B1E1B233-C27F-45D6-8476-24B8C0A2270AQ51407916-4DDD7E88-1CCD-47B1-86DF-FBFB75A3ABB6Q53652399-47A3E6FA-FF54-4973-9C50-53C3BF372F03
P2860
An update on biomarkers of bone turnover and their utility in biomedical research and clinical practice.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
An update on biomarkers of bon ...... esearch and clinical practice.
@ast
An update on biomarkers of bon ...... esearch and clinical practice.
@en
type
label
An update on biomarkers of bon ...... esearch and clinical practice.
@ast
An update on biomarkers of bon ...... esearch and clinical practice.
@en
prefLabel
An update on biomarkers of bon ...... esearch and clinical practice.
@ast
An update on biomarkers of bon ...... esearch and clinical practice.
@en
P2093
P1476
An update on biomarkers of bon ...... esearch and clinical practice.
@en
P2093
Alexandersen P
Karsdal MA
Leeming DJ
Schaller S
P2888
P304
P356
10.1007/S00228-006-0174-3
P577
2006-08-16T00:00:00Z